Olema Pharmaceuticals, Inc.
SAN FRANCISCO, California, United States · Biotechnology, Healthcare, Health Care
Olema Pharmaceuticals is a preclinical biotechnology company.
Key facts
- Headquarters
- SAN FRANCISCO, California, United States
- Employees
- Unknown
- Industries
- Biotechnology, Healthcare, Health Care
- Status
- Public (OLMA)
- Website
- olemapharma.com
Recent activity at Olema Pharmaceuticals, Inc.
- : Olema Pharmaceuticals Appoints Jason O’Byrne as Chief Financial Officer
- : SEC 8-K (1.02): On November 18, 2025, Olema Pharmaceuticals, Inc. announced the termination of its at-the-market prospectus related to the sale of its common stock. This decision effectively halts any sales under the Sales Agreement dated January 6, 2025, with TD Securities (USA) LLC, unless a new prospectus or registration statement is filed. The termination reflects the company's strategic financial management, potentially impacting its capital raising efforts. The Sales Agreement itself, however, remains in effect despite the termination of this specific prospectus.
- : Olema Pharmaceuticals, Inc. announces FDA clearance for OP-3136, aimed at targeting breast cancer treatment.
- : Olema Pharmaceuticals Announces New Clinical Trial Collaboration and Supply Agreement with Novartis in Frontline Metastatic Breast Cancer and $250 Million Equity Private Placement
- : Olema Pharmaceuticals, Inc.
- : Olema Pharmaceuticals, Inc.
- : Olema Pharmaceuticals, Inc.
- : Olema Pharmaceuticals, Inc.
Olema Pharmaceuticals, Inc. funding history
| Date | Round | Amount |
|---|---|---|
| Oct 2020 | Venture | $87.4M |
| Jun 2020 | Venture | $53.9M |
| Mar 2020 | Venture | $30.0M |
| Aug 2018 | Venture | $6.1M |
Leadership
- Michael Hwang, Associate Director
- Sean Bohen, Executive Officer, Director
- Cynthia Butitta, Director
- Ian Clark, Director
- Cyrus Harmon, Executive Officer, Director
- Gorjan Hrustanovic, Director
- Frank McCormick, Director
- Andrew Rappaport, Director
- Graham Walmsley, Director
- Cyrus Harmon, Executive Officer, Director
- Frank McCormick, Director
- Andrew Rappaport, Director
Verified email and direct lines for Olema Pharmaceuticals, Inc.’s decision-makers are on Fundz. See plans
Companies similar to Olema Pharmaceuticals, Inc.
- AIM ImmunoTech · Biotechnology, Healthcare, Health Care, Pharmaceutical, Therapeutics
- EyePoint Pharmaceuticals, Inc. · Biotechnology, Healthcare, Health Care, Pharmaceutical, Therapeutics
- AbbVie Inc. · Biotechnology, Healthcare, Health Care, Pharmaceutical, Therapeutics
- Reneo Pharmaceuticals, Inc. · Biotechnology, Healthcare, Health Care, Pharmaceutical, Therapeutics
- Imago BioSciences, Inc. · Biotechnology, Healthcare, Health Care, Pharmaceutical, Therapeutics
About Olema Pharmaceuticals, Inc.: questions and answers
What does Olema Pharmaceuticals, Inc. do?
Olema Pharmaceuticals is a preclinical biotechnology company.
Where is Olema Pharmaceuticals, Inc. headquartered?
Olema Pharmaceuticals, Inc. is headquartered in SAN FRANCISCO, California, United States.
Has Olema Pharmaceuticals, Inc. raised funding?
Yes. Fundz has recorded 4 funding events for Olema Pharmaceuticals, Inc.. The most recent, $87.4M, was in Oct 2020.
What is the latest news on Olema Pharmaceuticals, Inc.?
On Aug 13, 2026, Olema Pharmaceuticals Appoints Jason O’Byrne as Chief Financial Officer
Is Olema Pharmaceuticals, Inc. a public company?
Yes. Olema Pharmaceuticals, Inc. is publicly traded under the ticker OLMA.
Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy